bf/NASDAQ:IMMX_icon.jpeg

COM:IMMIXBIO

Immix Biopharma, Inc.

  • Stock

Last Close

2.15

26/07 20:00

Market Cap

59.17M

Beta: -

Volume Today

125.04K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Sep '20
Dec '20
Mar '21
Jun '21
Sep '21
Dec '21
Mar '22
Jun '22
Sep '22
Dec '22
Mar '23
Jun '23
Sep '23
Dec '23
Mar '24
net income
-116.32K
-
-765.58K
558.17%
-1.02M
32.80%
-208.64K
79.48%
-403.26K
93.28%
-22.76M
5,542.77%
-1.33M
94.15%
-1.56M
17.32%
-1.54M
1.77%
-3.80M
147.54%
-2.50M
34.26%
-3.60M
44.04%
-4.34M
20.72%
-5.09M
17.16%
-5.33M
4.75%
depreciation and amortization
580
-
581
0.17%
608
4.65%
620
1.97%
620
0%
620
0%
620
0%
383
38.23%
566
47.78%
566
0%
505
10.78%
506
0.20%
1.38K
172.92%
3.08K
122.74%
23.85K
675.36%
deferred income tax
825K
-
-90K
110.91%
22.11M
-
-295.16M
-
-193.94K
99.93%
535.76K
376.25%
-605.12K
212.95%
stock based compensation
4.25K
-
30.72K
623.43%
61.86K
101.34%
122.15K
97.47%
65.07K
46.73%
65.71K
0.98%
163.19K
148.36%
230.09K
41.00%
329.92K
43.38%
447.66K
35.69%
737.33K
64.71%
943.26K
-
change in working capital
44.02K
-
348.93K
692.70%
-141.34K
140.51%
89.56K
163.37%
269.90K
201.37%
-609.16K
325.70%
-228.47K
62.49%
899.62K
493.76%
-141.20K
115.70%
-334.75K
137.08%
75.61K
122.59%
-365.30K
583.12%
518.55K
241.95%
1.42M
174.62%
accounts receivables
-29.26K
-
-60.95K
108.32%
-72.19K
18.44%
24.95K
134.56%
-380.24K
1,624.06%
-465.93K
22.54%
inventory
29.26K
-
60.95K
108.32%
147.80K
142.50%
-24.95K
116.88%
380.24K
1,624.06%
accounts payables
43.01K
-
117.75K
173.79%
-141.99K
220.59%
75.36K
153.07%
267.47K
254.94%
-306.89K
214.74%
160.93K
152.44%
676.56K
320.42%
-330.54K
148.86%
624.79K
289.02%
190.81K
69.46%
937.49K
391.33%
451.96K
51.79%
854.22K
89.00%
1.92M
125.32%
other working capital
1.01K
-
231.18K
22,789.21%
652
99.72%
14.20K
2,078.53%
2.44K
82.84%
-302.27K
12,498.20%
-389.39K
28.82%
223.06K
157.28%
189.34K
15.11%
-959.54K
606.77%
-190.81K
80.11%
-1.30M
582.78%
66.59K
105.11%
1.04M
1,455.42%
other non cash items
575K
-
61.69K
89.27%
19.73K
68.02%
20.12K
2.00%
16.62K
17.40%
50K
-
50K
0%
295.16M
590,212%
193.94K
99.93%
-535.76K
376.25%
605.12K
212.95%
984.95K
62.77%
net cash provided by operating activities
-71.72K
-
158.93K
321.60%
-266.45K
267.65%
-158.01K
40.70%
-50.76K
67.88%
-1.11M
2,094.87%
-1.49M
34.17%
-547.07K
63.40%
-1.46M
167.33%
-3.90M
166.94%
-2.09M
46.41%
-3.52M
68.04%
-3.09M
12.19%
-2.68M
13.26%
-3.83M
42.93%
investments in property plant and equipment
-802
-
802
-
-38.91K
-
-13.18K
66.14%
-301.91K
2,191.21%
acquisitions net
purchases of investments
sales maturities of investments
other investing activites
net cash used for investing activites
-802
-
802
-
-2.91M
-
-38.91K
-
-13.18K
66.14%
-301.91K
2,191.21%
debt repayment
common stock issued
18.65M
-
2.91M
84.38%
2.91B
-
278.92K
99.99%
4.71M
1,587.78%
10.13M
115.08%
821.31K
91.89%
15.95M
1,841.55%
common stock repurchased
-55.96K
-
-44K
-
dividends paid
other financing activites
65K
-
82.33K
26.66%
-18.35K
122.29%
71.02K
487.06%
-50K
-
-2.91B
-
-160K
99.99%
-15.82K
90.11%
-58.80K
271.75%
-234.62K
299.01%
2.49K
101.06%
net cash used provided by financing activities
65K
-
82.33K
26.66%
-18.35K
122.29%
18.72M
102,121.67%
2.91M
84.44%
-105.96K
103.64%
2.91M
2,849.78%
424.28K
85.44%
118.92K
71.97%
4.69M
3,845.36%
10.07M
114.56%
586.69K
94.17%
15.95M
2,618.39%
effect of forex changes on cash
5.74K
-
44.12K
668.39%
-8.04K
118.23%
5.49K
168.22%
-3.50K
163.75%
621
117.75%
-2.72K
538.33%
-5.30K
94.86%
-23.34K
340.06%
-157
99.33%
-562
257.96%
14.14K
2,615.48%
-11.77K
183.26%
31.29K
365.81%
net change in cash
-65.98K
-
203.06K
407.75%
-210.29K
203.56%
-70.19K
66.62%
-72.61K
3.44%
17.61M
24,349.35%
1.42M
91.96%
-658.33K
146.49%
-1.49M
125.70%
-3.48M
134.20%
-1.97M
43.28%
1.19M
160.32%
6.93M
482.04%
-2.07M
129.91%
11.81M
669.78%
cash at beginning of period
254.01K
-
188.03K
25.98%
391.09K
107.99%
180.79K
53.77%
110.60K
38.83%
37.99K
65.65%
17.64M
46,338.95%
19.06M
8.03%
18.40M
3.45%
16.92M
8.07%
13.44M
20.57%
11.46M
14.69%
12.65M
10.39%
19.58M
54.76%
17.51M
10.58%
cash at end of period
188.03K
-
391.09K
107.99%
180.79K
53.77%
110.60K
38.83%
37.99K
65.65%
17.64M
46,338.95%
19.06M
8.03%
18.40M
3.45%
16.92M
8.07%
13.44M
20.57%
11.46M
14.69%
12.65M
10.39%
19.58M
54.76%
17.51M
10.58%
29.32M
67.44%
operating cash flow
-71.72K
-
158.93K
321.60%
-266.45K
267.65%
-158.01K
40.70%
-50.76K
67.88%
-1.11M
2,094.87%
-1.49M
34.17%
-547.07K
63.40%
-1.46M
167.33%
-3.90M
166.94%
-2.09M
46.41%
-3.52M
68.04%
-3.09M
12.19%
-2.68M
13.26%
-3.83M
42.93%
capital expenditure
-802
-
802
-
-38.91K
-
-13.18K
66.14%
-301.91K
2,191.21%
free cash flow
-71.72K
-
158.93K
321.60%
-267.25K
268.15%
-158.01K
40.88%
-50.76K
67.88%
-1.11M
2,093.29%
-1.49M
34.27%
-547.07K
63.40%
-1.46M
167.33%
-3.90M
166.94%
-2.09M
46.41%
-3.52M
68.04%
-3.13M
11.09%
-2.69M
13.92%
-4.13M
53.45%

All numbers in (except ratios and percentages)